Biodegradation of the copolymeric polylactide stent: Long-term follow-up in a rabbit aorta model

Journal of Vascular Research

Volumn 38, Issue 4, 2001, Pages 361-369

  Hietala, Eeva Maija ^a   Salminen, Ulla Stina ^a   Ståhls, Anders ^a   Välimaa, Tero ^b   Maasilta, Paula ^a   Törmälä, Pertti ^b   Nieminen, Markku S ^a   Harjula, Ari L J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Bioabsorbable stent; Biodegradable polylactide; Experimental study; Stent materials

Indexed keywords

ACETYLSALICYLIC ACID; COPOLYMER; ENOXAPARIN; POLYLACTIDE; TICLOPIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CORONARY STENT; FIBROSIS; FOLLOW UP; FOREIGN BODY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ABSORBABLE IMPLANTS; ANIMALS; AORTA; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CALCINOSIS; ENDOTHELIUM, VASCULAR; FIBROSIS; FOREIGN-BODY REACTION; HEMOSIDERIN; INFLAMMATION; LYMPHOCYTES; MACROPHAGES; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; POLYESTERS; RABBITS; STENTS; TIME FACTORS; VASCULAR PATENCY;

EID: 0034912732     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051067     Document Type: Article

References (27)

1. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review
2. Randomized comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease
3. Chronic critical lower limb ischemia: Prospective trial of angioplasty with 1-36 months follow-up
4. Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: Importance of aggressive interventional approach and role of transcutaneous oximetry
5. Clinical and anatomical considerations for nonoperative therapy in tibial disease and results of angioplasty
6. Coronary stent placement in patients with acute myocardial infarction: Comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy
7. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries
8. Experimental study of thrombogenecity and foreign body reaction induced by heparin-coated coronary stents
9. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo
10. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A
11. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits
12. Endovascular irradiation for the prevention of restenosis after percutaneous transluminal angioplasty
13. Antiproliferative stent coatings: Taxol and related compounds
14. Stent-based delivery of sirolismus for the prevention of restenosis
15. Medetomidine-ketamine-diazepam anesthesia in the rabbit
16. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and wall stents in canine iliac and femoral arteries
17. Pathology of acute and chronic coronary stenting in humans
18. Granulomatous 'foreign body reactions' contribute to exaggerated in-stent restenosis
19. Cellular growth and differentiation
20. Heterotopic chondro-osteoplastic metaplasia of the subclavian vein wall after long-term catheterization. Case report
21. Biocompatibility aspects of new stent technology
22. A bioabsorbable self-expandable, self-reinforced poly-L-lactide acid urethral stent for recurrent urethral strictures: A preliminary report
23. Bioabsorbable self-reinforced poly-L-lactide, metallic, and silicone stents in the management of experimental tracheal stenosis
24. A novel polymeric local heparin delivery stent: Initial experimental study
25. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall
26. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans